We are live on ! Find out more
BAM

Bellevue Asset Management Portfolio holdings

AUM $217M
1-Year Est. Return 14.36%
This Fund
S&P 500
This Quarter Est. Return
+9.62%
1 Year Est. Return
+14.36%
3 Year Est. Return
+56.75%
5 Year Est. Return
+72.55%
10 Year Est. Return
AUM
$159M
AUM Growth
+$12M
Cap. Flow
-$824K
Cap. Flow %
-0.52%
Top 10 Hldgs %
70.19%
Holding
498
New
14
Increased
92
Reduced
56
Closed
20

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$637K
2
AAPL icon
Apple
AAPL
+$173K
3
SBUX icon
Starbucks
SBUX
+$93.2K
4
COST icon
Costco
COST
+$48.1K
5
RTX icon
RTX Corp
RTX
+$44.8K

Sector Composition

Rank Sector Weight
1 Technology 42.47%
2 Consumer Discretionary 7.81%
3 Consumer Staples 3.86%
4 Healthcare 2.82%
5 Financials 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSM icon
426
Insmed
INSM
$28.9B
$1.71K ﹤0.01%
81
JPST icon
427
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
$1.7K ﹤0.01%
+34
New +$1.71K
EEM icon
428
iShares MSCI Emerging Markets ETF
EEM
$29.2B
$1.7K ﹤0.01%
43
ENV
429
DELISTED
ENVESTNET, INC.
ENV
$1.66K ﹤0.01%
28
FWONK icon
430
Liberty Media Series C
FWONK
$25B
$1.66K ﹤0.01%
23
-1
-4% -$71
ROK icon
431
Rockwell Automation
ROK
$49.1B
$1.65K ﹤0.01%
5
-5
-50% -$1.44K
IYW icon
432
iShares US Technology ETF
IYW
$24.8B
$1.63K ﹤0.01%
15
QS icon
433
QuantumScape Corp
QS
$3.4B
$1.6K ﹤0.01%
200
VIAV icon
434
Viavi Solutions
VIAV
$10B
$1.57K ﹤0.01%
139
SPCE icon
435
Virgin Galactic
SPCE
$377M
$1.55K ﹤0.01%
20
RPRX icon
436
Royalty Pharma
RPRX
$25.4B
$1.54K ﹤0.01%
50
PAY icon
437
Paymentus
PAY
$5.05B
$1.52K ﹤0.01%
144
TEVA icon
438
Teva Pharmaceuticals
TEVA
$40.6B
$1.51K ﹤0.01%
200
A icon
439
Agilent Technologies
A
$39.9B
$1.44K ﹤0.01%
12
CTVA icon
440
Corteva
CTVA
$51.3B
$1.43K ﹤0.01%
25
FNDF icon
441
Schwab Fundamental International Large Company Index ETF
FNDF
$25.2B
$1.42K ﹤0.01%
44
IT icon
442
Gartner
IT
$11.7B
$1.4K ﹤0.01%
4
TWNK
443
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$1.39K ﹤0.01%
55
SONO icon
444
Sonos
SONO
$1.83B
$1.39K ﹤0.01%
85
LYG icon
445
Lloyds Banking Group
LYG
$90B
$1.39K ﹤0.01%
630
-849
-57% -$1.95K
NRDY icon
446
Nerdy
NRDY
$107M
$1.38K ﹤0.01%
331
HIMS icon
447
Hims & Hers Health
HIMS
$6.87B
$1.37K ﹤0.01%
146
GM icon
448
General Motors
GM
$76.3B
$1.35K ﹤0.01%
35
SCHO icon
449
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
$1.34K ﹤0.01%
56
ASND icon
450
Ascendis Pharma A/S
ASND
$16.4B
$1.34K ﹤0.01%
15

Similar funds

Bellevue Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Bellevue Asset Management held 498 positions worth $159M, up 8.1% from $147M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Bellevue Asset Management's Q2 2023 filing shows 14 new, 92 increased, 56 reduced and 20 closed positions. Its largest new stake was Saba Capital Income & Opportunities Fund: 420 shares worth $3.23K. The largest sale was Microsoft, an estimated $637K.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 40% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Bellevue Asset Management's largest Q2 2023 buy was Saba Capital Income & Opportunities Fund: 420 shares worth $3.23K.
  • Bellevue Asset Management added most to First Trust Value Line Dividend Fund in Q2 2023, an estimated $245K increase.
  • Bellevue Asset Management's biggest Q2 2023 reduction was Microsoft, cutting an estimated $637K.
  • Bellevue Asset Management fully exited Nuveen AMT-Free Quality Municipal Income Fund in Q2 2023, selling an estimated $17.7K.
  • Bellevue Asset Management's ten largest holdings make up 70% of its $159M portfolio in Q2 2023.
  • Bellevue Asset Management opened 14 new positions and closed 20 in Q2 2023.
  • Bellevue Asset Management's portfolio value rose 8.1% quarter-over-quarter to $159M.

Based on Bellevue Asset Management's 13F filing for Q2 2023, filed 31 Jul 2023.